% | $
Quotes you view appear here for quick access.

Amarin Corporation plc Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • jesse.livermore jesse.livermore Nov 14, 2012 7:08 PM Flag

    Exclusivity, NCEs patents, generics..


    The REDUCE-IT study and the NCE are only tangentially related. The NCE effects the H-W exclusivity period and REDUCE-IT' being "substantially underway" is an FDA requirement for the sNDA allowing Vascepa to be FDA approved for the dyslipidemia clinical indication. An indication that is over ten times the size of the FDA indication for which the drug is approved at present...So the answer is, of course you continue REDUCE-IT....

    ": ) JL

    Sentiment: Strong Buy

2.09+0.05(+2.45%)12:10 PMEDT